Industry / DCVMN / PhRMA / EFPIA / IFPMA / BIO Watch [to 18 July 2015]
:: GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed
Jul 16, 2015, 08:00 ET GSK announced today it has begun shipping FLUARIX® QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research
:: Sanofi Pasteur Ships First 2015-2016 Seasonal Influenza Vaccine Doses in United States
Jul 14, 2015, 08:00 ET Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2015-2016 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment.